Antinuclear antibody formation following administration of anti-tumor necrosis factor agents in Japanese patients with psoriasis

被引:5
|
作者
Yanaba, Koichi [1 ]
Umezawa, Yoshinori [1 ]
Honda, Hiromi [1 ]
Sato, Reiko [1 ]
Chiba, Miki [1 ]
Kikuchi, Sota [1 ]
Asahina, Akihiko [1 ]
Nakagawa, Hidemi [1 ]
机构
[1] Jikei Univ, Sch Med, Dept Dermatol, 3-25-8 Nishishimbashi, Tokyo 1058461, Japan
来源
JOURNAL OF DERMATOLOGY | 2016年 / 43卷 / 04期
关键词
ALPHA THERAPY; AUTOANTIBODIES; INFLIXIMAB;
D O I
10.1111/1346-8138.13215
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:443 / 444
页数:2
相关论文
共 50 条
  • [21] Update on Anti-Tumor Necrosis Factor Agents in Crohn Disease
    Singh, Siddharth
    Pardi, Darrell S.
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2014, 43 (03) : 457 - +
  • [22] Anti-Tumor Necrosis Factor Agents in Inflammatory Eye Disease
    Lowder, Careen
    Choudhary, Maria
    Hajj-ali, Rula
    Srivastava, Sunil
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [23] Cost-effectiveness of anti-tumor necrosis factor agents
    Wong, JB
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2004, 22 (05) : S65 - S70
  • [24] Strategies for Treatment With Anti-Tumor Necrosis Factor Agents in Psoriasis Maintaining Efficacy and Safety for the Long Haul
    Gordon, Kenneth B.
    Gandhi, Mona
    ARCHIVES OF DERMATOLOGY, 2010, 146 (02) : 186 - 188
  • [25] Improvement of pyoderma gangrenosum and psoriasis associated with Crohn disease with anti-tumor necrosis factor α monoclonal antibody
    Tan, MH
    Gordon, M
    Lebwohl, O
    George, J
    Lebwohl, MG
    ARCHIVES OF DERMATOLOGY, 2001, 137 (07) : 930 - 933
  • [26] Tumor Necrosis Factor and Anti-Tumor Necrosis Factor Therapies
    Keystone, Edward C.
    Ware, Carl F.
    JOURNAL OF RHEUMATOLOGY, 2010, 37 : 27 - 39
  • [27] Dermatomyositis associated with anti-tumor necrosis factor therapy in a patient with psoriasis
    Dicaro, Dane
    Bowen, Casey
    Dalton, Scott R.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 70 (03) : E64 - E65
  • [28] Psoriasis induced by anti-tumor necrosis factor therapy: A class effect?
    Richette, Pascal
    Viguier, Manuelle
    Bachelez, Herve
    Bardin, Thomas
    JOURNAL OF RHEUMATOLOGY, 2007, 34 (02) : 438 - 439
  • [29] Efficacy comparison of ustekinumab between anti-tumor necrosis factor-α drug-naive and anti-tumor necrosis factor-α drug-resistant psoriasis patients
    Lopez Jimenez, Patricio
    Suarez Perez, Jorge Alonso
    Herrera Acosta, Enrique
    Mendiola Fernandez, Maria Victoria
    Fernandez Crehuet, Pablo
    Guimera Martin-Neda, Francisco
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB118 - AB118
  • [30] Predictors of Infection in Rheumatoid Arthritis Patients Using Anti-Tumor Necrosis Factor Agents
    Liu, Tasia
    Caffrey, Aisling R.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 54 - 54